Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Jia, J; Li, H; Dellinger, A; Pang, H; Russell, KB; Hurwitz, H; Nixon, AB

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X